Mavens Biotech Limited - Due diligence report

A 360° intelligence report on Mavens Biotech Limited: trust score, financial health, credit view, compliance, directors, growth and distress…

1981-10-24 Kolkata, West Bengal Active Listed Active Compliant
Share
MB Mavens Biotech Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Mavens Biotech Limited — 360° Intelligence Report

Generated from MCA filings & public records
74/100
Trust Score
Moderate

Mavens Biotech Limited is assessed as Moderate with a Trust Score of 74/100. Mavens Biotech Limited is an active public limited indian non-government company incorporated in 1981, operating in the Agriculture sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and moderate financial risk profile.

Report generated on 16 Jul 2026 from the latest processed filings. Mavens Biotech Limited snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
74/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
70/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
60/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
55/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
50/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 55/100 Moderate
  • Negative operating earnings - debt service depends on external support.
  • No open charges - unencumbered balance sheet.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 70/100 Moderate
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Flagged by authority: SEBI.
05

Director Intelligence

Stability score: 85/100
NameDIN / PANDesignationAppointedTenureDIN status
ABHISHEK KUMAR JAIN 01234567 Director 01/04/2018 6 yrs Approved
JAY PRAKASH 01234567 Director 01/04/2018 6 yrs Approved
SAURAV NARANG 01234567 Director 01/04/2018 6 yrs Approved
SUNITA HANUMAN SINGHI 01234567 Director 01/04/2018 6 yrs Approved
BISWAJIT BARUA 01234567 Director 01/04/2018 6 yrs Approved
MANOJ KUMAR 01234567 Director 01/04/2018 6 yrs Approved
Jay Prakash 01234567 Director 01/04/2018 6 yrs Approved
  • 7 directors on the board.
  • No disqualified or deactivated DINs.
  • 3 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
0 allotment(s) · 1 transfer(s)

Promoters hold the largest single block of equity - exact percentages are part of the full report.

Key managerial personnel: ABHISHEK KUMAR JAIN (CFO) · JAY PRAKASH (Managing Director)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 50 · Distress 75
Growth signals & trust indicators
Profit expanded 38% year-on-year.
Operating for 44+ years.
Distress signals & risk flags
Revenue declined year-on-year.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence73/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment60/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view60/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
11 Aug 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
11 Aug 2024
Director ceased
SUNITA HANUMAN SINGHI
26 Jun 2024
Director appointed
SUNITA HANUMAN SINGHI (Director)
24 Jun 2024
Director appointed
Jay Prakash (Ceo)
10 Sep 2023
Director ceased
BISWAJIT BARUA
04 Aug 2023
Director appointed
ABHISHEK KUMAR JAIN (CFO)
Director ceased
GANGA SAHAI
26 Jul 2023
Director appointed
BISWAJIT BARUA (Director)
28 Jan 2022
Director appointed
JAY PRAKASH (Managing Director)
Director ceased
JAY PRAKASH
27 Jan 2022
Director ceased
KULDEEP DOSHI
16 Sep 2021
Director ceased
MANOJ KUMAR
10 Nov 2020
Director ceased
SHARMILA RANABHAT
01 Oct 2020
Director appointed
MANOJ KUMAR (Director)
10

Key Observations

Auto-generated from the data above
Revenue declined 1.42 over the last 4 financial year(s).
Net worth is positive.
7 active director(s) / partner(s); board looks stable and experienced.
Promoters hold the largest single block of equity as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Vishwakarma Marcom Private Limited U51909WB2011PTC161946 Kolkata, West Bengal, India
Meadows Infracon Private Limited U70101DL2011PTC218114 Delhi, Delhi, India
Shashvata Infratech Private Limited U45200DL2007PTC171941 Delhi, Delhi, India
Riddhi Projects Private Limited U45202GJ2007PTC059511 Ahmedabad, Gujarat, India
Dlf Ltd U45200TN2008PLC067001 Chennai, Tamil Nadu, India
Sanvi Creations Private Limited U45200CT2007PTC020453 Raipur, Chattisgarh, India
Aashna Realcon Private Limited U45201RJ2008PTC026352 Jaipur, Rajasthan, India
Legal Talky Real Estates Private Limited U70100MP2010PTC023957 Jawad, Madhya Pradesh, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Mavens Biotech Limited before audits and certifications: compliance score 70/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Mavens Biotech Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 55/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 50/100, margin trends, ownership structure and peer set for Mavens Biotech Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 74/100, distress signals and MSME payment-delay disclosures - know whether Mavens Biotech Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Mavens Biotech Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Mavens Biotech Limited an active company?

Mavens Biotech Limited has MCA status “Active” with a compliance score of 70/100 (Moderate).

Is Mavens Biotech Limited financially healthy?

Mavens Biotech Limited has a Financial Health Score of 60/100 (Moderate) based on its filed financial statements.

Should I do business with Mavens Biotech Limited?

Its overall Trust Score is 74/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Mavens Biotech Limited?

Promoters hold the largest single block of equity - exact percentages are in the full report. 7 active director(s) are on record.

Does Mavens Biotech Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Mavens Biotech Limited up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 70/100 (Moderate).

Is it risky to lend to Mavens Biotech Limited?

Its Credit Risk Score is 55/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.